The content of this page is aimed at providing information and guidance on Immunotherapy Toxicity to healthcare professionals. Information for patients can be found HERE.
All Wales Immunotherapy Toxicity Group
Chair: Tracy Parry, SACT Lead Pharmacist for Cancer Network and Lead Cancer Services Pharmacist for Betsi Cadwaladr University Health Board
Deputy Chair: Dr Ricky Frazer, Consultant Medical Oncologist, Velindre Cancer Centre
The All Wales Immunotherapy Toxicity Group has been established by the Wales Cancer Network as a subgroup of the All Wales Acute Oncology Service (AOS) Group and All Wales Systemic Anti-Cancer Therapy (SACT) Group. It aims to provide a strategic lead for immunotherapy toxicity priorities and a forum for the ratification of all Wales developments enabling a coordinated approach to service provision.
For further information on the All Wales Immunotherapy Toxicity Group, please contact WCN.WalesCancerNetwork@wales.nhs.uk
National Immuno-Oncology (IO) Education Forum
The national immuno-oncology education forum is a multi-disciplinary meeting that was established by Helen Winter, Consultant from Bristol Haematology and Oncology Centre, and Ricky Frazer, Consultant at Velindre Cancer Centre in Cardiff. It has grown to more than 100 colleagues from across the whole of the UK that come together once a month to discuss immunotherapy related topics. Topics covered so far include recognising myasthenia gravis, management of colitis and review of national steroid guidelines. The National IO Education Forum is open to all healthcare professionals regardless of experience; the only requirement is an interest in immunotherapy and a desire to improve patient care. The meetings take place virtually via Microsoft Teams on the first Thursday of every month at 1pm regardless of the date it falls on and lasts no more than 1 hour. If you are interested in joining the National IO Education Forum, please contact Ricky Frazer on Ricky.Frazer@wales.nhs.uk or the team on VCCNational.IOEducationForum@wales.nhs.uk.
Systemic Anti-Cancer Treatment (SACT)
The All Wales SACT Group has been established by the Wales Cancer Network. It aims to provide a strategic lead for national SACT priorities, enabling a coordinated approach for developments such as e-prescribing, SACT datasets, coordination and monitoring of horizon scanning of cancer drugs and accessibility on a once for Wales basis.
For further information about SACT and the All Wales SACT Group please CLICK HERE.
Acute Oncology Service (AOS)
The All Wales AOS Group was established by the Wales Cancer Network and aims to provide a strategic lead for national acute oncology priorities and a forum for the ratification of All Wales developments enabling a coordinated approach, for example in the development of AOS datasets, pathways, documents and support tools in order to ensure a standardised, cohesive acute oncology service for Wales.
For further information about AOS and the All Wales AOS Group, please CLICK HERE.